Printer Friendly

SPECTRASCIENCE ELECTS McMAHON PRESIDENT AND CHIEF EXECUTIVE OFFICER

 MINNEAPOLIS, May 14 /PRNewswire/ -- Brian T. McMahon has been elected president and chief executive officer of SpectraScience, Inc., (NASDAQ: SPSC) the company announced today. McMahon, the company's executive vice president and chief operating officer since July 1992, was also elected a member of the company's board of directors. Daryl F. Yurik, previously chairman of the board and CEO, remains chairman of the board.
 The company also announced that shareholders elected two new directors at the annual meeting yesterday. They are Gary S. Kohler, vice president of Okabena Company, a private investment company, and Nathaniel Thayer, an attorney and partner in the law firm of Blais Cunningham and Crowe Chester.
 McMahon has extensive domestic and international medical products experience. He held a succession of marketing, sales management and business development positions with SciMed Life Systems, Inc., Minneapolis, during a period of explosive growth.
 SpectraScience designs, develops, manufactures and markets laser- enhanced systems for the diagnosis and treatment of cardiovascular disease. The company's development efforts currently are focused mainly on a laser diagnostic system. SpectraScience is based in Minneapolis.
 -0- 5/14/93
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000, for SpectraScience; or Tom Ahmann of SpectraScience, 612-559-4000/
 (SPSC)


CO: SpectraScience, Inc. ST: Minnesota IN: MTC SU: PER

AL -- MN015 -- 8708 05/14/93 14:42 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 14, 1993
Words:216
Previous Article:WTC INDUSTRIES, INC. ANNOUNCES FIRST QUARTER RESULTS
Next Article:NATIONAL DATACOMPUTER, INC. REPORTS
Topics:


Related Articles
SPECTRASCIENCE GETS TOTAL OF $3,252,998 FROM WARRANT EXERCISE
SPECTRASCIENCE INSTITUTES CASH CONSERVATION MEASURES, COMPLETING PRODUCT DEVELOPMENT ACTIVITIES
COMPANY WILL RESUME CLINICAL TRIALS AS A RESULT OF PRODUCT ENHANCEMENTS; PRODUCT COMMERCIALIZATION ANTICIPATED IN 1994; DIRECTOR RESIGNS
SPECTRASCIENCE FILES 510K WITH FOOD AND DRUG ADMINISTRATION
SpectraScience Appoints Stanley Pappelbaum, M.D. as Director.
SpectraScience Strengthens Leadership Team With Four Key Hires.
Annual Shareholders Meeting to Be Held May 5, 2008 at the University Club in St. Paul, MN.
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic.
SpectraScience Adds Industry Veteran to Executive Team.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters